Medicine and Dentistry
Patient
100%
Combination Therapy
45%
Non Small Cell Lung Cancer
37%
Inpatient
31%
Epidermal Growth Factor Receptor
29%
Cells
29%
Lung Adenocarcinoma
28%
Lung Cancer
27%
Programmed Cell Death
25%
Survival
25%
Cancer Cell
24%
Mortality
20%
Epidermal Growth Factor Receptor Kinase Inhibitor
17%
Progression Free Survival
16%
Follow up
13%
Health
12%
Computer Assisted Tomography
12%
down Regulation
12%
Chronic Obstructive Pulmonary Disease
12%
Growth
12%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
12%
Disease
12%
Chest
11%
Hazard Ratio
11%
Lung
11%
Idiopathic Pulmonary Fibrosis
11%
Glass
11%
Lung Nodule
11%
Chemotherapy
11%
Crohn's Disease
11%
Tyrosine-Kinase Inhibitor
10%
Age
10%
Overall Survival
9%
X Linked Inhibitor of Apoptosis
9%
Diagnosis
9%
Female
9%
Mutant
8%
Malignant Neoplasm
8%
Erlotinib
8%
Gefitinib
8%
Silo-Filler's Disease
7%
Pleura Effusion
7%
Prognosis
6%
Male
6%
Lung Biopsy
6%
Epidermal Growth Factor Receptor
6%
Exon
6%
Analysis
6%
Pancreas Cancer
6%
In Vitro
6%
Pharmacology, Toxicology and Pharmaceutical Science
Apoptosis
50%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
45%
Non Small Cell Lung Cancer
42%
Malignant Neoplasm
41%
Breast Cancer
29%
Cell Death
24%
Progression Free Survival
21%
Neoplasm
17%
Survival
16%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Chronic Obstructive Lung Disease
15%
Mortality
14%
Reactive Oxygen Metabolite
13%
Protein Mcl 1
13%
Protein Tyrosine Kinase Inhibitor
13%
Lung Cancer
12%
Pancreas Cancer
12%
Activating Transcription Factor 4
11%
Epidermal Growth Factor Receptor
11%
Lung Adenocarcinoma
11%
Adult Respiratory Distress Syndrome
11%
X Linked Inhibitor of Apoptosis
11%
Elastase
11%
Mouse
11%
Death Receptor 5
11%
Vitamin D Deficiency
11%
Overall Survival
10%
Cytotoxicity
9%
Gefitinib
8%
Pneumonia
7%
Histone
7%
Emphysema
7%
Metastasis
6%
Calcium
6%
Anticarcinogen
6%
Cyclin Dependent Kinase 9
6%
Leukemia
6%
Histone Methyltransferase
6%
Drug Repositioning
6%
Diseases
6%
Docetaxel
6%
Hospital Mortality
6%
Toxicity
5%
Fibrosing Alveolitis
5%
Adenosine A3 Receptor Antagonist
5%
Potentiation
5%
Acute Myeloid Leukemia
5%
Liver Cell Carcinoma
5%
Survivin
5%
Rhabdomyolysis
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
21%
Apoptosis
18%
Mutation
18%
Epidermal Growth Factor Receptor
16%
Unfolded Protein Response
12%
Nested Gene
12%
Cell Death
12%
Small Molecule
12%
Data Base
8%
Histone Methyltransferase
8%
Endoplasmic Reticulum Stress
7%
Health
6%
Phosphorylation
6%
Genome Wide Association Study
5%
Ultrasound
5%
Activating Transcription Factor 4
5%
Calcium Cell Level
5%
Calcium Mobilization
5%
Circulating Tumor DNA
5%
Histone Deacetylase
5%
Liquid
5%
Progression Free Survival
5%
Pharmacogenetic Testing
5%
Drug Sensitivity
5%
Angiogenesis
5%
Tumor Volume
5%
Electronic Health Record
5%
Pediatrics
5%
CRISPR
5%
Gene Locus
5%
SOX2
5%
down Regulation
5%
Forced Vital Capacity
5%
Tumor Necrosis Factor
5%
Genome-Wide Association Study
5%
Survival Rate
5%
Vitamin D
5%
Myeloid
5%
Adenine
5%
